Cancer medicines

Dasatinib

Dasatinib

A targeted therapy for Philadelphia chromosome-positive leukemias.

Sources checked · Introductory guide

On this page

How it works

It inhibits growth signaling through tyrosine kinases including BCR-ABL.[3]

Where it is used

Used in selected Ph-positive CML or ALL according to disease status and prior treatment.[1]

Key safety points

Report new breathlessness, chest pain, swelling or bleeding immediately. Review all medicines, including acid suppressants and antacids.[2]

Questions for your care team

  • How are molecular response, lung or heart symptoms and gastric-medicine interactions monitored?

Sources and scope

Source documents are in English.

Entries summarize and translate linked official public sources. The source-check date records when those sources were checked; it does not indicate a clinician’s review.

  1. NCI · Dasatinib (opens in a new tab)
  2. MedlinePlus · Dasatinib (opens in a new tab)
  3. NCI Drug Dictionary · Dasatinib (opens in a new tab)

General information based on official public sources. This is not a complete list of uses or side effects. Individual treatment decisions require your care team and current source documents. US-source uses do not establish local approval or reimbursement.

Related entries

Dasatinib | Cancer Encyclopedia | My Chemo Diary